Related Experiment Video
Updated: Jun 11, 2026
06:58
Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
Noradrenergic modulation of seizure activity
T Chachua1, I Bilanishvili, N Khizanishvili
1I. Beritashvili Institute of Physiology, Department of Neurophysiology, Tbilisi, Georgia.
Georgian Medical News
|July 13, 2010
Summary
Norepinephrine synapses in the brain play a key role in modulating epilepsy. Activating alpha-2 norepinephrine receptors blocks hippocampal seizures, while blocking them intensifies seizure activity.
Area of Science:
- Neuroscience
- Epileptology
- Pharmacology
Background:
- Epilepsy pathogenesis mechanisms remain insufficiently understood.
- Identifying brain structures, transmitters, and receptors modulating seizures is crucial.
- The locus coeruleus, a norepinephrine-producing area, is an endogenous epilepsy modulator.
Purpose of the Study:
- To assess the significance of norepinephrine synapses in local hippocampal seizure development.
- To investigate the role of alpha-2 norepinephrine receptors in seizure modulation.
Main Methods:
- Adult rats were used in chronic experimental conditions.
- Microinjections of clonidine (alpha-2 agonist) and yohimbine (alpha-2 antagonist) were administered.
- The effects on local hippocampal seizure activity (without behavioral manifestation) were evaluated.
Main Results:
- Microinjection of an alpha-2 norepinephrine receptor agonist blocked local hippocampal seizures.
- Microinjection of an alpha-2 norepinephrine receptor antagonist potentiated seizure power.
- These findings highlight the modulatory role of norepinephrine in seizure activity.
Conclusions:
- The effects of the locus coeruleus on seizures are likely mediated by the activation of alpha-2 norepinephrine receptors.
- Norepinephrine synapses are important targets for understanding and potentially treating epilepsy.
More Related Videos
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...